Pharmaceutical Excipients
Pharmaceutical ExcipientsThe Pharmaceutical Excipients editor board consists of pharmaceutical scientists with extensive expertise in drug formulation and experience of working with excipients. As the primary connection between Pharmaceutical Excipients and the field, editors inform and help set the content strategy, addressing developments of the field. Bringing expert knowledge and insight from their own specialism, Editors also provide content steering support on individual excipient records and chapters.
Bruno C Hancock
BPharm, PhD
Bruno is a US-based editor from the pharmaceutical industry. Bruno’s career in formulation development includes working on spray dried dispersions, powder technology, and product design, including computational drug product design. Along with editing Pharmaceutical Excipients, he has co-authored several chapters. This includes a short-form resource on the use of counterions, and a colourful overview of the history of excipients.
David J Goldfarb
BS, MEng, PhD
David is a US-based industry expert currently leading a group that support late-stage product development. His work in formulation and process development covers oral solid and liquid dosage forms as well as topicals. David was also one of the first chapter authors, developing a key resource on excipient functional categories for the Handbook.
Gary P Moss
BSc, MSc, PhD
Gary is a senior lecturer in Pharmaceutics in UK Academia. Gary brings a wealth of expertise in the topical use of excipients to the board, with a current research focus on experimental and in silico percutaneous absorption. With over 10 years’ experience as contributing author, he has also served as a member of the advisory board, the International Steering Committee.
Members of the International Steering Committee provide a broader range of expertise to further steer content development and strategy for Pharmaceutical Excipients and support the Editor board and Pharmaceutical Press team on delivering quality content. Their collective expertise includes the design, development, analysis, manufacture, and application of pharmaceutical excipients and dosage forms, as well as different routes of administration and key specialist areas depending on field dynamics. The ISC provide a global perspective, with seats spanning North America, Europe, the UK, and Asia, and across academic, industry, and publishing sectors.
International Steering Committee
Alberto Berardi
Pfizer Inc, Boxmeer, Netherlands
Vivek S Dave
St John Fisher College, Wegmans School of Pharmacy, Rochester, NY, USA
David J Goldfarb
Merck & Co, Inc, Rahway, NJ, USA
Bruno C Hancock
Westerly, RI, USA
Stephen W Hoag
University of Maryland at Baltimore, Baltimore, MD, USA
Oisín N Kavanagh
Newcastle University, Newcastle, UK
Bruce R Kinsey
Ashland Specialty Ingredients, Harleysville, PA, USA
William J Lambert
Incline Village, NV, USA
Rebecca Luckhurst
Pharmaceutical Press, Royal Pharmaceutical Society, London, UK
R Christian Moreton
FinnBrit Consulting, Waltham, MA, USA
Gary Moss
Keele University, Keele, UK
Roger New
Diabetology (UK) Limited and Middlesex University, London, UK
David Schoneker
Black Diamond Regulatory Consulting LLC, PA, USA
Shirish A Shah
EZRA Pharma LLC, Phoenix, AZ, USA
Kamalinder K Singh
University of Central Lancashire, Preston, UK
Changquan Calvin Sun
College of Pharmacy, University of Minnesota, Minneapolis, MN, USA
Hirofumi Takeuchi
Gifu Pharmaceutical University, Gifu, Japan
Mike Tobyn
Bristol Myers Squibb, Moreton, UK
Jiasheng Tu
China Pharmaceutical University, Nanjing, China
Alberto Berardi
Pfizer Inc, Boxmeer, Netherlands
Vivek S Dave
St John Fisher College, Wegmans School of Pharmacy, Rochester, NY, USA
David J Goldfarb
Merck & Co, Inc, Rahway, NJ, USA
Bruno C Hancock
Westerly, RI, USA
Stephen W Hoag
University of Maryland at Baltimore, Baltimore, MD, USA
Oisín N Kavanagh
Newcastle University, Newcastle, UK
Bruce R Kinsey
Ashland Specialty Ingredients, Harleysville, PA, USA
William J Lambert
Incline Village, NV, USA
Rebecca Luckhurst
Pharmaceutical Press, Royal Pharmaceutical Society, London, UK
R Christian Moreton
FinnBrit Consulting, Waltham, MA, USA
Gary Moss
Keele University, Keele, UK
Roger New
Diabetology (UK) Limited and Middlesex University, London, UK
David Schoneker
Black Diamond Regulatory Consulting LLC, PA, USA
Shirish A Shah
EZRA Pharma LLC, Phoenix, AZ, USA
Kamalinder K Singh
University of Central Lancashire, Preston, UK
Changquan Calvin Sun
College of Pharmacy, University of Minnesota, Minneapolis, MN, USA
Hirofumi Takeuchi
Gifu Pharmaceutical University, Gifu, Japan
Mike Tobyn
Bristol Myers Squibb, Moreton, UK
Jiasheng Tu
China Pharmaceutical University, Nanjing, China
Contributors to Pharmaceutical Excipients leverage their expert understanding of excipients into valuable content additions, authoring new chapters and monographs, or contributing to the maintenance of existing records. Contributions can include support on nomenclature updates, expert knowledge of an excipient’s practical application, or it’s physicochemical data.
Contributors
O AbuBaker GlaxoSmithKline Inc, Collegeville, PA, USA
KS Alexander University of Toledo, Toledo, OH, USA
LV Allen Jr Edmond, OK, USA
FA Alvarez-Nunez Amgen Inc, Thousand Oaks, CA, USA
GE Amidon University of Michigan, Ann Arbor, MI, USA
GP Andrews The Queen’s University of Belfast, Belfast, UK
VD Antle Ligand Pharmaceuticals Inc, Lawrence, KS, USA
A Antic Deakin University, Geelong, Victoria, Australia
S Apte Colleyville, TX, USA
AZM Badruddoza Groton, CT, USA
D Bahl Amgen Inc, Thousand Oaks, CA, USA
D Baker Ridgefield, Connecticut, USA
R Balgley Amgen Inc, Thousand Oaks, CA, USA
S Bandari School of Pharmacy, University of Mississippi, Oxford, MS, USA
BC Bejgum Amgen Inc, Thousand Oaks, CA, USA
ES Beevor London, UK
R Bradley Bayer Corporation, Whippany, NJ, USA
M Bond Reigate, UK
CG Cable Edinburgh, UK
J Camargo Omya International AG, Switzerland
S Cantor Huntersville, NC, USA
RN Cawthorne Croda Europe Ltd, Goole, East Yorkshire, UK
MB Cepok Mannheim, Germany
SP Chamarthy Amgen Inc, Thousand Oaks, CA, USA
WG Chambliss University of Mississippi, University, MS, USA
RK Chang Silver Spring, MD, USA
SY Chang Minneapolis, MN, USA
R Chen Pfizer Inc, Groton, CT, USA
DK Chiappetta Boehringer-Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA
JG Clarke GlaxoSmithKline, Hertfordshire, UK
WG Cook Mylan Global R&D, Sandwich, Kent, UK
L Contreras Pfizer Global R&D, Sandwich, Kent, UK
CE Correa-Soto Thousand Oaks, CA, USA
A Cram Pfizer Global R&D, Sandwich, Kent, UK
JR Creekmore AstraZeneca Pharmaceuticals LP, Wilmington, DE, USA
EE Crehan-Kwong Pharmaceutical Press, Royal Pharmaceutical Society, London, UK
N Culver Pfizer Inc, Groton, CT, USA
TC Dahl Gilead Sciences, Foster City, CA, USA
D Das Bayer Corporation, Whippany, NJ, USA
D Daurio Amgen Inc, Thousand Oaks, CA, USA
VS Dave Rochester, NY, USA
ML Dawson GlaxoSmithKline, Hertfordshire, UK.
S Dharani College Station, Tx, USA
E Draganoiu Lubrizol Advanced Materials Inc, Cleveland, OH, USA
S Driver London, UK
MS Dudhedia New Haven, CT, USA
AD Eads Grain Processing Corporation, Muscatine, IA, USA
C English Pfizer Global R&D, Sandwich, Kent, UK
M Foley CIMA Labs Inc, Brooklyn Park, MN, USA
SO Freers Grain Processing Corporation, Muscatine, IA, USA
S Fulzele Brooklyn Park, MN, USA
SS Fulzele Cargill Inc, Eden Prairie, MN, USA
D Gates Pfizer Inc, Groton, CT, USA
T Gavankar VAV Lipids Pvt Ltd, Mumbai, India
M Ghimire Harleysville, PA, USA
K Gochioco Thousand Oaks, CA, USA
PL Goggin Broadstairs, Kent, UK
DJ Goldfarb Merck & Co, Inc, Rahway, NJ, USA
SR Goskonda Sunnyvale, CA, USA
RT Guest Royston, Hertfordshire, UK
Y Guo College of Pharmacy, University of Minnesota, Minneapolis, MN, USA
RT Gupta Braintree, MA, USA
B Gururajan Basel-Stadt, Switzerland
F Guth BASF SE, Limburgerhof, Germany
BC Hancock Westerly, RI, USA
BA Hanson Schering-Plough Research Institute, Summit, NJ, USA
O Häusler Roquette Europe, Lestrem, France
X He Boehringer-Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA
J Heimlich Pfizer Inc, Groton, CT, USA
P Heljo University of Helsinki, Helsinki, Finland
D Hirsh Boehringer Ingelheim, Ridgefield, CT, USA
SW Hoag University of Maryland at Baltimore, Baltimore, MD, USA
K Hogrefe Mannheim, Germany
JC Hooton AstraZeneca, Macclesfield, Cheshire, UK
K Hughes Colorcon Limited, Dartford, Kent, UK
WL Hulse University of Bradford, Bradford, UK
MR Huo China Pharmaceutical University, Nanjing, China
NJ Irwin Queen’s University Belfast, Belfast, UK
R Ivone Kingston, RI, USA
CG Jange Amgen Inc, Thousand Oaks, CA, USA
BR Jasti University of the Pacific, Stockton, CA, USA
Q Jiang Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA
DS Jones The Queen’s University Belfast, Belfast, UK
A Juppo University of Helsinki, Helsinki, Finland
S Juvekar Mumbai, Maharashtra, India
BV Kadri Houston, TX, USA
S Kambalapally Umass Medical School, Elkridge, MD, USA
O Kavanaugh Newcastle, UK
A Kedia VAV Lipids Pvt Ltd, Mumbai, India
T Kekatpure Bayer Corporation, Whippany, NJ, USA
VL Kett Belfast, UK
AH Kibbe Wilkes-Barre, PA, USA
B Khorsand Amgen Inc, Thousand Oaks, CA, USA
S Koranne Merck & Co Inc, Rahway, NJ, USA
GS Laghate Mumbai, India
WJ Lambert Incline Village, NV, USA
JX Li Prinston Pharmaceutical Inc, Cranbury, NJ, USA
X Li Stockton, CA, USA
H-P Lim University of Maryland at Baltimore, Baltimore, MD, USA
EB Lindblad Copenhagen, Denmark
T Lipiäinen University of Helsinki, Helsinki, Finland
H Lou Amgen Inc, Thousand Oaks, CA, USA
PE Luner Triform Sciences LLC, Waterford, CT, USA
R Maheswaran Silver Spring, MD, USA
S Manthena CT, USA
BR Matthews Consultant, Surrey, UK
CP McCoy Queen’s University Belfast, Belfast, UK
RK Mehta Harleysville, PA, USA
M Mishra Eurofins Professional Scientific Services Ireland Ltd, Dungarvan, Ireland
EM Mohamed College Station, Tx, USA
F Monsuur W. R. Grace & Co, Worms, Germany
RC Moreton FinnBrit Consulting, Waltham, MA, USA
G Moss Keele University, Keele, Staffordshire, UK
C Mroz Colorcon Ltd, Dartford, Kent, UK
MP Mullarney Pfizer Inc, Groton, CT, USA
BJ Murphy Pfizer Inc, Groton, CT, USA
R Nair Silver Spring, MD, USA
S Nema Cambridge, MA, USA
DX Nguyen Amgen Inc, Thousand Oaks, CA, USA
S Obara Shin-Etsu Chemical Co Ltd, Niigata, Japan
E Oga Preston, UK
A Palanisamy Basel-Stadt, Switzerland
A Palmieri Gainesville, FL, USA
JB Park University of Mississippi, University, MS, USA
C Parry Pharmaceutical Press, Royal Pharmaceutical Society, London, UK
M Pastuszka Vividion Therapeutics, San Diego, CA, USA
H Patil Somerset, NJ, USA
L Peltonen Helsinki, Finland
M Peltoniemi University of Helsinki, Helsinki, Finland
Y Peng AstraZeneca Pharmaceuticals, Wilmington, DE, USA
FK Penz Molkerei MEGGLE Wasserburg mbH & Co KG, Wasserburg, Germany
MB Perez-Cuevas Amgen Inc, Thousand Oaks, CA, USA
N Petrovsky Adelaide, Australia
JD Pipkin Ligand Pharmaceuticals Inc, Lawrence, KS, USA
A Pirjanian Amgen Inc, Thousand Oaks, CA, USA
F Podczeck University College London, London, UK
S Proisy Dow France S.A.S. (affiliated company of The Dow Chemical Company), Chauny, France
G Pulmones Amgen Inc, Thousand Oaks, CA, USA
W Qu Silver Spring, MD, USA
J Quadflieg W. R. Grace & Co, Worms, Germany
ME Quinn London, UK
A Rajabi-Siahboomi Harleysville, PA, USA
LG Rajewski Ligand Pharmaceuticals Inc, Lawrence, KS, USA
M Rane Colorcon Inc, Harleysville, PA, USA
RD Reddy Pfizer Inc, Groton, CT, USA
MA Repka University of Mississippi, University, MS, USA
B Richard Pacira Pharmaceuticals Inc, San Diego, CA, USA
D Richter W. R. Grace & Co, Worms, Germany
S Rieschl CIMA Labs Inc, Brooklyn Park, MN, USA
C Rollins Eastman Chemical Company, Kingsport, TN, USA
RC Rowe Intelligensys Ltd (Retired), Stokesley, UK
S Sahu Amgen Inc, Thousand Oaks, CA, USA
N Sandler Åbo Akademi University, Turku, Finland
P Satturwar Toronto, ON, Canada
N Sawant Amgen Inc, Thousand Oaks, CA, USA
T Schmeller BASF SE, Limburgerhof, Germany
DR Schoneker Black Diamond Regulatory Consulting LLC, Lansdale, PA, USA
J Schrier Pacira Pharmaceuticals Inc, San Diego, CA, USA
R Schwabe Boehringer-Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA
CJ Sciarra Sciarra Laboratories, Hickesville, NY, USA
JJ Sciarra Sciarra Laboratories, Hickesville, NY, USA
R Sengupta Thousand Oaks, CA, USA
HC Shah Mumbai, India
SA Shah Phoenix, AZ, USA
US Shah Cary, NC, USA
PJ Sheskey The Dow Chemical Company (Retired), Midland, MI, USA
J Shur University of Bath, Bath, UK
D Simon Roquette Frères, Lestrem, France
AB Singaraju Eli Lilly and Company, Indianapolis, IN, USA
KK Singh Preston, UK
IL Smales Pfizer Inc, Sandwich, Kent, UK
R Smith London, UK
JLP Soh Pfizer Global R&D, Sandwich, Kent, UK
XSong National Institutes for Food and Drug Control, Beijing, China
C Subra Gattefossé SAS, Saint-Priest, France
CC Sun College of Pharmacy, University of Minnesota, Minneapolis, MN, USA
A Tailor Mumbai, Maharashtra, India
K Tao Shanghai, China
P Thipsay Pfizer Inc, Groton, Connecticut, USA
N Tirumalesh W. R. Grace & Co, Hyderabad, India
SB Tiwari Ridgewood, NJ, USA
EJ Tocce Dow Chemical Co, Michigan, USA
N Trivedi Silver Spring, MD, USA
B Truitt San Diego, CA, USA
CK Tye Lexington, MA, USA
A Ubhe Irvine, CA, USA
S Vaithianathan Bayer Corporation, Whippany, NJ, USA
T Vogel Pfizer Inc, Groton, CT, USA
Z Wang College of Pharmacy, University of Minnesota, Minneapolis, MN, USA
M Watters London, UK
P Wen Shanghai, China
GK Wu FDA, Silver Spring, MD, USA
M Wylie Belfast, UK
R Yang National Institutes for Food and Drug Control, Beijing, China
T Yeoh Salem, CT, USA
P Ying Pacira Pharmaceuticals Inc, San Diego, CA, USA
Z Zhang China Food and Drug Administration, Beijing, China
JA Zeleznik IMCD US, Lakewood, OH, USA
The Pharmaceutical Excipients Partners
Pharmaceutical Excipients is published jointly by APhA and Pharmaceutical Press.